×
About 10,975 results

ALLMedicine™ Ankylosing Spondylitis Center

Research & Reviews  2,922 results

Hyperextension-distraction fractures in ankylosing and spondylotic spines: injury profi...
https://doi.org/10.1007/s00264-022-05310-7 10.1038/sj.sc.3100837 10.1007/s002560050503 10.1097/BSD.0b013e3181679bcb 10.1007/s00296-002-0237-4 10.21037/jss.2019.09.11 10.1007/s00296-009-1216-9 10.1097/BRS.0b013e3181cc764f 10.1007/s001130170003 10.1007/s00586-008-0764-0 10.1097/BRS.0000000000001115 10.1016/j.clineuro.2015.10.014 10.1007/s00590-013-1375-y 10.1016/j.jocn.2016.01.020 10.14444/3023
International Orthopaedics; Cirillo T JI, Gimbernat R M et. al.

Jan 22nd, 2022 - Case series study. To describe demographic metrics, and clinical and radiographical outcomes of surgical treatment in patients with ankylosed spine (ASP) such as diffuse idiopathic skeletal hyperostosis (DISH) or ankylosing spondylitis (AS) and no...

Review of publications evaluating opioid use in patients with inflammatory rheumatic di...
https://doi.org/10.1097/BOR.0000000000000868
Current Opinion in Rheumatology; Anastasiou C, Yazdany J

Jan 20th, 2022 - This article discusses publications assessing the prevalence, efficacy, and safety of opioid analgesics in patients with rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, ankylosing spondylitis,...

The Effects of Tele-Yoga in Ankylosing Spondylitis Patients
https://clinicaltrials.gov/ct2/show/NCT04803383

Jan 19th, 2022 - Yoga is an ancient discipline that emerged in India thousands of years ago, designed to bring balance and health to the physical, mental, emotional and spiritual dimensions of the individual.Due to its therapeutic effects, yoga can be considered a...

Patient knowledge of gut microbiota and acceptability of fecal microbiota transplantati...
https://doi.org/10.1111/nmo.14320
Neurogastroenterology and Motility : the Official Journal... Benech N, Legendre P et. al.

Jan 18th, 2022 - Fecal microbiota transplantation (FMT) is now evaluated in various diseases. However, large-scale population treatment may encounter feasibility issues in terms of acceptance. We aim to evaluate patient knowledge of gut microbiota and the acceptab...

Impact of the number of comorbidities on the outcome measures and on the retention rate...
https://doi.org/10.1016/j.semarthrit.2021.12.007
Seminars in Arthritis and Rheumatism; Puche-Larrubia MÁ, Ladehesa-Pineda L et. al.

Jan 15th, 2022 - To evaluate the impact of the number of comorbidities on the outcome measures after two years of follow-up in patients with Ankylosing Spondylitis (AS) and to determine whether the number of comorbidities influences the retention rate of the first...

see more →

Guidelines  11 results

2019 Update of the American College of Rheumatology/Spondylitis Association of America/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.

Aug 23rd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...

Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients ...
https://www.ncbi.nlm.nih.gov/pubmed/30717501
Pain Physician; Kaye AD, Manchikanti L et. al.

Feb 6th, 2019 - Interventional pain management involves diagnosis and treatment of chronic pain. This specialty utilizes minimally invasive procedures to target therapeutics to the central nervous system and the spinal column. A subset of patients encountered in ...

The effectiveness, safety, and economic evaluation of Korean medicine for unexplained i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779787
Medicine

Mar 6th, 2018 - Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in 2012, but the evidence for these recommendations was only of indirect nature. These recommendations were re-evaluated in light of new insights. Based on the ...

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
https://doi.org/10.1136/annrheumdis-2016-210770
Annals of the Rheumatic Diseases; van der Heijde D, Ramiro S et. al.

Jan 15th, 2017 - To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA) into one set applicable to the full spectrum of patients with...

EULAR recommendations for cardiovascular disease risk management in patients with rheum...
https://doi.org/10.1136/annrheumdis-2016-209775
Annals of the Rheumatic Diseases; Agca R, Heslinga SC et. al.

Oct 5th, 2016 - Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the European League Against Rheumatism (EULAR) taskforce recommend...

see more →

Drugs  768 results see all →

Clinicaltrials.gov  133 results

The Effects of Tele-Yoga in Ankylosing Spondylitis Patients
https://clinicaltrials.gov/ct2/show/NCT04803383

Jan 19th, 2022 - Yoga is an ancient discipline that emerged in India thousands of years ago, designed to bring balance and health to the physical, mental, emotional and spiritual dimensions of the individual.Due to its therapeutic effects, yoga can be considered a...

A Study of CC-99677 in Participants With Active Ankylosing Spondylitis
https://clinicaltrials.gov/ct2/show/NCT04947579

Jan 11th, 2022 - This study is designed to learn about response to CC-99677 treatment by measuring signs and symptoms of Ankylosing Spondylitis (AS), objective measures of disease activity, quality of life assessments, pharmacokinetics, safety, and tolerability ov...

A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic ...
https://clinicaltrials.gov/ct2/show/NCT04527380

Jan 5th, 2022 - The reason for this study is to see if the study drug ixekizumab is safe and effective in children with juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) (including juvenile onset ankylosing spondylitis [JoAS]) a...

A Study to Assess Disease Activity in Adult Participants With Ankylosing Spondylitis Who Receive Upadacitinib in a Real-world Setting
https://clinicaltrials.gov/ct2/show/NCT05094128

Dec 20th, 2021 - Axial spondyloarthritis (axSpA), which encompasses radiographic axSpA (r-axSpA, also known as ankylosing spondylitis [AS]) is an immune-mediated inflammatory disease primarily affecting the axial skeleton. The most frequent axSpA symptom is chroni...

Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)
https://clinicaltrials.gov/ct2/show/NCT03259074

Dec 14th, 2021 - The purpose of this study is to demonstrate the impact of secukinumab on progression of structural damage in the spine, as measured by the mSASSS in patients with AS.

see more →

News  542 results

Crohn's Disease Scores With Interchangeable Humira Biosimilar
https://www.medpagetoday.com/gastroenterology/inflammatoryboweldisease/96469

Dec 31st, 2021 - On October 18, 2021, MedPage Today reported on the approval of Cyltezo, the first interchangeable biosimilar approval for adalimumab (Humira), covering a range of indications, including Crohn's disease (CD). Here we provide a follow up to this sto...

Tofacitinib Approved for New Ankylosing Spondylitis Indication
https://www.medscape.com/viewarticle/964978

Dec 16th, 2021 - The US Food and Drug Administration (FDA) approved a supplemental new drug application for tofacitinib (Xeljanz, Xeljanz XR) that adds active ankylosing spondylitis in adults to its list of indications, according to a December 14 announcement from...

Year in Review: Crohn's Disease
https://www.medpagetoday.com/gastroenterology/inflammatoryboweldisease/96216

Dec 15th, 2021 - Cyltezo, the first interchangeable biosimilar for adalimumab (Humira), was approved for Crohn's disease, while research continued on additional therapeutic options, including a study that compared two different biologics head-to-head. Studies also...

Upadacitinib (Rinvoq) Gains Psoriatic Arthritis as Second FDA-Approved Indication
https://www.medscape.com/viewarticle/964858

Dec 15th, 2021 - The US Food and Drug Administration has approved a 15-mg extended release tablet of upadacitinib (Rinvoq) for adults with psoriatic arthritis who had an inadequate response or intolerance to one or more anti-tumor necrosis factor drugs, manufactur...

Peripheral manifestations make mark on spondyloarthritis trajectory
https://www.mdedge.com/rheumatology/article/249542/spondyloarthropathies/peripheral-manifestations-make-mark
Heidi Splete

Dec 7th, 2021 - Peripheral manifestations contribute significantly to disease activity in adults with spondyloarthritis (SpA), point toward a generally worse prognosis, and play a big role in defining the phenotypic clustering of the heterogenous disease, accordi.

see more →

Patient Education  14 results see all →